- Companies
- Omni
Omni Revenue, Valuation, Funding & Investors
Omni is valued at $650M as of March 2025, a 65.0x multiple on its last reported $10M revenue.
Last Omni valuation
$650M
Series B · Mar 2025
Last Omni funding round
$69M
Series B · Mar 2025
Omni revenue
$10M
Series B · Mar 2025
Key investors in Omni
GV
First Round Capital
Flybridge
Redpoint
Highland Capital Partners
Bolt
Omni Overview
About Omni
OMNI is a Salt Lake City-based ophthalmology referral center offering advanced surgical treatments for retinal diseases, glaucoma, and cornea conditions. The practice performs vitrectomy, LASIK, and premium IOL implants without primary eye exams, collaborating with optometrists statewide. Established in 1985, OMNI employs 12 fellowship-trained surgeons across three Utah clinics, integrating Heidelberg spectral-domain OCT and argon laser systems.
Founded
1998
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Services
Revenue
$10M (Mar 2025)
Valuation
$650M (Mar 2025)
Sectors
Omni Valuation
Omni is currently valued at $650M, based on its Series B in March 2025.
The $69M round was led by ICONIQ Capital, with participation from Redpoint, Theory Ventures, First Round Capital, GV and Snowflake Ventures.
Omni's valuation has grown 6.5x from $100M at its Series A in August 2022 to $650M in March 2025, across 2 priced rounds.
Omni valuation by funding round
Revenue multiple| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Mar 2025 | Series B | $650M | 65.0x |
| Aug 2022 | Series A | $100M | - |
Omni Revenue
Omni's latest recorded revenue is $10M, as of its Series B in March 2025. At a $650M valuation, that implies a 65.0x revenue multiple.
Omni revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Mar 2025 | $10M | $650M | 65.0x | Series B |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
Omni Funding History
Omni has raised a total of $151M across 8 funding rounds.
Omni's first fundraising round was a $3M seed round in September 2014. The most recent completed round was a $69M Series B in March 2025.
Omni funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Mar 2025 | Series B | ICONIQ Capital (lead); Redpoint; Theory Ventures; First Round Capital; GV; Snowflake Ventures | $69M | $650M | Omni Analytics is a San Francisco-based business intelligence and embedded analytics platform that enables users to analyze, visualize, and share data using SQL, Excel syntax, AI natural language prompts, and dashboards, all grounded in a semantic layer for consistency and governance. Launched in 2022 with wider commercial availability from February 2023, Omni targets both internal analytics for employees and customer-facing data products, such as embedding graphs in marketing software to show ad performance metrics. The platform caches query results for efficiency and supports progression from basic visualizations to advanced custom insights without fragmentation. On March 13, 2025, Omni raised $69 million in a Series B funding round led by ICONIQ Growth, with participation from existing investors First Round Capital, GV (Google Ventures), Redpoint Ventures, Snowflake Ventures, and Theory Ventures, bringing total funding to $97 million. This round achieved a post-money valuation of $650 million, following a prior $20 million raise almost a year earlier. The funding reflects Omni's explosive growth, including 8x year-over-year increases in revenue and customer usage, with nearly $10 million in annualized revenue at the time and expectations to triple that by year-end 2025. Omni plans to use the proceeds to accelerate product development, particularly in embedded analytics features and spreadsheet data processing, while expanding headcount from 85 to 150 employees by the end of 2025 to support go-to-market efforts. CEO Colin Zima highlighted the round as a milestone on the company's third anniversary, positioning Omni to unify data exploration in a BI market criticized for complexity. The startup, founded by ex-Looker talent, differentiates through flexibility across user interfaces while ensuring trustworthy AI outputs via its semantic foundation, amid rising demand for scalable, intuitive data tools. |
| Mar 2024 | Undisclosed stage | Theory Ventures (lead) | $20M | - | Omni is a business intelligence platform founded by ex-Looker talent, enabling data exploration through SQL, spreadsheets, AI, and point-and-click interfaces in a unified environment. It addresses BI fragmentation by providing governed, flexible tools with a semantic layer for trustworthy insights, high adoption rates (up to 100% in first month), cost savings (up to 75% vs. Looker), and reduced data team queries (80%). Customers include The Rounds, Ascend, Rose Rocket, and Ubaq. On March 14, 2024, Omni raised $20 million from Theory Ventures (lead investor), described as additional capital to build the platform, add features like embedded analytics and Calculations AI, and enhance data access. Lambert Billet, former Looker CRO, joined the board. This follows earlier rounds: $3M seed in September 2014 and $250K convertible note in March 2015, bringing total raised to $55.3M as of early 2024. Theory Ventures' Tomasz Tunguz highlighted Omni's rapid progress in just two years, picking up from Looker gaps. A later Series B in March 2025 raised $69M led by ICONIQ Growth at $650M valuation with 8x YoY revenue growth, but details for the specific 2024 Theory Ventures round remain undisclosed. |
| Aug 2022 | Series A | Redpoint (lead); First Round Capital; GV | $18M | $100M | Omni is a unified business intelligence platform founded in early 2022 by executives from Looker and Stitch, including James Davidson, Jamie Davidson, and Chris Merrick. The platform automatically builds a sandbox data model as users query data using SQL, allowing promotion of metrics to a shared organizational model, combining consistency of enterprise BI with flexibility and speed. It targets data teams and business users to reduce trade-offs between centralized reporting and agile analytics, filling the gap between instant analytics tools and mature BI systems. On August 16, 2022, Omni publicly launched alongside announcement of $26.9 million in total funding, comprising a $17.5 million Series A led by Redpoint with participation from First Round Capital and GV, and a prior $9.4 million seed round led by First Round with Redpoint, GV, Box Group, Quiet, Scribble, and over 100 angels. The Series A post-money valuation reached close to $100 million. Funds support platform development, team expansion from about 16 employees, go-to-market efforts, and customer acquisition beyond initial development partners. Parker Conrad of Rippling praised Omni's platform for enabling consistency, reliability, and speed in compound startups. Tomasz Tunguz of Redpoint highlighted the team's ambition to advance BI, joining the board. Omni positions against legacy BI platforms like Looker by streamlining data modeling and collaboration. |
| Apr 2022 | Seed | First Round Capital (lead); Redpoint; GV; BoxGroup; Scribble Ventures; Quiet Capital | $9M | - | - |
| Jan 2018 | Series B | Highland Capital Partners; Stefan Thomas; Founders Fund; Allen & Company | $25M | - | Omni is a business intelligence (BI) platform that combines a shared data model with SQL flexibility, enabling consistent data analysis. The company raised $25 million in a Series B round in January 2018, with investors including Allen & Company, Founders Fund, Highland Capital Partners, and Stefan Thomas, to support growth and expand marketplace operations. Total funding across rounds reached $55.3 million by March 2025, including a later $20 million Series Unknown round in March 2024 led by Theory Ventures for platform development, data access enhancements, and cost reductions. A subsequent $20 million raise in 2024 aimed at adding features like embedded analytics and Calculations AI, with Lambert Billet joining the board. |
| May 2016 | Series A | Highland Capital Partners (lead); TMWRK; Freddie Wexler; Flybridge; George Arison; Precursor Ventures; Colin Carrier; Loic Le Meur; James Cash; Kevin Lin; Bolt | $7M | - | Omni was a San Francisco-based marketplace platform facilitating rentals of various items, categorized under apps, marketplace, and mobile industries. The company raised a Series A round of $7 million in May 2016 led by Highland Capital Partners, bringing total funding to $10 million at that point. Other investors included Theory Ventures in later rounds, though Omni has since permanently closed. The 2016 round aimed to scale the platform and enhance technological capabilities. Omni operated as a private entity with 101 to 250 employees. |
| Mar 2015 | Pre-seed | Flybridge | $300K | - | - |
| Sep 2014 | Seed | Drake; Ellen Levy; 8VC; Darling Ventures; David Carrico; Flybridge; Formation 8; Ido Leffler; David Maestri; Atsushi Nouchi; FPXA Holdings; Bolt | $3M | - | - |
Who has invested in Omni?
33 investors have backed Omni across its funding rounds, including GV, First Round Capital, Flybridge, Redpoint, Highland Capital Partners and Bolt.
Lead investors include ICONIQ Capital, Theory Ventures, Redpoint, First Round Capital and Highland Capital Partners.
Omni Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 3 | Lead | Apr 2022 | ||
| 3 | Lead | Apr 2022 | ||
| 3 | Participant | Apr 2022 | ||
| 3 | Participant | Sep 2014 | ||
| 2 | Lead | Mar 2024 | ||
| 2 | Lead | May 2016 | ||
| 2 | Participant | Sep 2014 | ||
| 1 | Participant | May 2016 | ||
| 1 | Lead | Mar 2025 | ||
| 1 | Participant | Sep 2014 | ||
| -- | 1 | Participant | May 2016 | |
| 1 | Participant | Sep 2014 | ||
| 1 | Participant | Jan 2018 | ||
This data is available for Pro users. Sign up to see all 33 Omni investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by Omni
Omni has acquired 4 companies to date.
Last acquisition by Omni was on October 22nd 2025. Omni acquired Explo for undisclosed valuation.
Latest Acquisitions by Omni
| Description | San Francisco-headquartered Explo operates a no-code data exploration platform founded in 2019. It connects to databases and warehouses for point-and-click analysis, visualization, and insight sharing without SQL requirements, serving analytics teams in tech and enterprise settings. | Erie Retinal Surgery is a retina specialty clinic in Erie, Pennsylvania, treating vitreoretinal diseases with advanced diagnostics and surgery. The practice performs vitrectomy, scleral buckling, and intravitreal injections for conditions like macular degeneration, diabetic retinopathy, and retinal detachment. Board-certified ophthalmologists utilize OCT imaging and fluorescein angiography, serving patients from northwest Pennsylvania and partnering with regional hospitals for 24/7 emergency retinal care. | Ludwick Eye Center is an Elyria-based ophthalmology practice in Ohio offering cataract surgery, LASIK, glaucoma treatment, and routine vision care from its facilities in Lorain County. | Corneal Associates of New Jersey is a Fair Lawn-based ophthalmology practice specializing in corneal transplants, cataract surgery, and external eye diseases. The group performs DSEK, DMEK, and Boston keratoprosthesis procedures at affiliated hospitals in northern New Jersey. Physicians hold fellowships from Wills Eye Hospital and serve as faculty at Rutgers New Jersey Medical School. Established in 1985, the practice manages complex cases referred from optometrists across Bergen and Passaic counties. |
| HQ Country | ||||
| HQ City | San Francisco, CA | Erie, PA | Chambersburg, PA | Bridgeport, CT |
| Deal Date | 22 Oct 2025 | 8 Apr 2021 | 15 Apr 2019 | 29 Jan 2019 |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed |
| EV/Revenue | ||||
| EV/EBITDA | ||||
This data is available for Pro users. Sign up to see all Omni acquisitions and their M&A valuation multiples. Start Free Trial | ||||
Omni Competitors
Omni competitors include listed companies like Al-Maidan Dental Clinic, Global Medical Response, Integral Diagnostics and Diagnósticos da América, and private ones like Harbor Health and Neuberg Diagnostics.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $650M | - | ||
| Publicly listed | $205M | $37M | $645M | - | ||
| Private | $107M | - | $642M | 6.0x | ||
| Publicly listed | $5.7B | $1.1B | $684M | 0.9x | ||
| Publicly listed | $561M | $99M | $616M | 1.8x | ||
| Publicly listed | $2.2B | $346M | $688M | 1.0x |
Omni Public Comps
Omni is still privately-owned, but its public comps include Al-Maidan Dental Clinic, Global Medical Response, Integral Diagnostics, Diagnósticos da América, Hermina Hospitals, Gushengtang Holdings, Saudi German Health, Garofalo Health Care, Chularat Hospital and WELL Health.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $205M | $37M | 2.4x | - | 13.0x | - | |||
| $5.7B | $1.1B | 0.9x | 0.9x | 4.7x | - | |||
| $561M | $99M | 1.8x | 1.8x | 10.2x | 8.4x | |||
| $2.2B | $346M | 0.9x | 1.0x | 5.6x | 4.9x | |||
| $402M | $104M | 2.1x | 1.9x | 8.1x | 7.5x | |||
| $484M | $93M | 1.6x | - | 8.3x | - | |||
| $827M | $204M | 1.7x | 1.6x | 6.8x | 8.3x | |||
| $559M | $83M | 1.5x | 1.4x | 9.8x | 8.6x | |||
This data is available for Pro users. Sign up to see all Omni competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Omni
| When was Omni founded? | Omni was founded in 1998. |
| Where is Omni headquartered? | Omni is headquartered in Iselin, NJ, United States. |
| Is Omni publicly listed? | No, Omni is a private, VC-backed company. |
| What is Omni's valuation? | Omni was last valued at $650M in its Series B in March 2025. |
| How much funding has Omni raised? | Omni has raised $151M across 8 funding rounds. |
| What was Omni's last funding round? | Omni's last funding round was a $69M Series B in March 2025, led by ICONIQ Capital. |
| Who are Omni's investors? | Omni's investors include Redpoint, First Round Capital, GV, Flybridge, Theory Ventures, Highland Capital Partners, Bolt, TMWRK, ICONIQ Capital, Drake and 23 others. |
| What is Omni's revenue? | Omni's latest recorded revenue is $10M (March 2025). |
| What is Omni's revenue multiple? | Omni's latest valuation implies a 65.0x revenue multiple ($650M valuation on $10M of revenue). |
| Which companies are comparable to Omni? | Companies comparable to Omni include Harbor Health, Al-Maidan Dental Clinic, Neuberg Diagnostics, Global Medical Response, Integral Diagnostics and Diagnósticos da América. |
| How many companies has Omni acquired? | Omni has acquired 4 companies, including Explo, Erie retinal surgery, Ludwick Eye Center and Corneal Associates of New Jersey. |
See companies similar to Omni
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




